PPA
OPTN

Parametric Portfolio Associates’s OptiNose OPTN Stock Holding History

Parametric Portfolio Associates’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-759
Closed -$34K – 3676
2021
Q3 		$34K Buy
+759
New +$31.8K ﹤0.01% 3591
2020
Q4 		– Sell
-906
Closed -$53K – 4017
2020
Q3 		$53K Sell
906
-82
-8% -$6.07K ﹤0.01% 3860
2020
Q2 		$110K Sell
988
-3,992
-80% -$284K ﹤0.01% 3763
2020
Q1 		$335K Sell
4,980
-2,968
-37% -$299K ﹤0.01% 3366
2019
Q4 		$1.1M Buy
7,948
+224
+3% +$29.1K ﹤0.01% 3017
2019
Q3 		$811K Buy
7,724
+5,149
+200% +$514K ﹤0.01% 3134
2019
Q2 		$273K Sell
2,575
-4,834
-65% -$637K ﹤0.01% 3620
2019
Q1 		$1.15M Buy
7,409
+1,382
+23% +$160K ﹤0.01% 2966
2018
Q4 		$561K Buy
6,027
+838
+16% +$120K ﹤0.01% 3256
2018
Q3 		$967K Buy
5,189
+4,690
+940% +$1.34M ﹤0.01% 3117
2018
Q2 		$209K Buy
+499
New +$168K ﹤0.01% 3682

Other funds holding OPTN

MPU
MVM Partners (UK) London, United Kingdom $149M AUM 6.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Parametric Portfolio Associates's OPTN Position: Q4 2021 in Review

Parametric Portfolio Associates sold out of OptiNose (OPTN) in Q4 2021, closing a stake of 759 shares — an estimated $34K sold.

Parametric Portfolio Associates first reported a position in OPTN in Q2 2018 and held it in 11 quarters. The position peaked at $1.15M in Q1 2019. 44 funds tracked by Wall St. Rank hold OPTN as of Q4 2021.

  • Parametric Portfolio Associates reported no remaining OptiNose position as of Q4 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 759 OptiNose shares in Q4 2021, an estimated $34K.
  • Parametric Portfolio Associates first reported a position in OptiNose in Q2 2018 and held it in 11 quarters.
  • Parametric Portfolio Associates's OptiNose position peaked at $1.15M in Q1 2019.
  • 44 funds tracked by Wall St. Rank held OptiNose as of Q4 2021.

Based on Parametric Portfolio Associates's 13F filing for Q4 2021, filed 15 Feb 2022.